Segment Information

We determined our reportable segments under the provisions of U.S. GAAP related to disclosures about segments of an enterprise. Management has concluded that Mobile Solutions, Power Solutions, and Life Sciences each constitutes an operating segment as each engages in business activities for which it earns revenues and incurs expenses for which separate financial information is available, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance. As described in Note 1, in January 2018, we implemented a new enterprise and management structure and reorganized our businesses into the Mobile Solutions, Power Solutions, and Life Sciences groups based principally on the end markets each group serves. In the first quarter of 2018, we began reporting our financial results based on these new reportable segments. Prior year amounts have been restated to conform to the current year presentation.

Mobile Solutions

Mobile Solutions is focused on growth in the general industrial and automotive end markets. We have developed an expertise in manufacturing highly complex, system critical components for fuel systems, engines and transmissions, power steering systems, and electromechanical motors on a high-volume basis. This expertise has been gained through investment in technical capabilities, processes and systems, and skilled program management and product launch capabilities.

Power Solutions

Power Solutions is focused on growth in the electrical and aerospace and defense end markets. Within this group we combine materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices used in applications ranging from power control to flight control and for military devices.

We manufacture a variety of products including electrical contacts, connectors, contact assemblies, and precision stampings for the electrical end market and high precision products for the aerospace and defense end markets utilizing our extensive process technologies for optical grade plastics, thermally conductive plastics, titanium, Inconel, magnesium, and electroplating.

Life Sciences

Life Sciences is focused on growth in the medical end market. Within this group we combine advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices.

We manufacture a variety of components, assemblies, and instruments, such as surgical knives, bioresorbable implants, surgical staples, cases and trays, orthopedic implants and tools, laparoscopic devices, and drug delivery devices for the medical and life sciences end market.

Segment Results

The following table presents results of continuing operations for each reportable segment.



	Mobile Solutions			Power Solutions			Life Sciences		Corporate and Consolidations				Total
Year Ended December 31, 2018
Net sales	$	335,037		$	189,778		$	248,173	$	(2,331	)	(a)	$	770,657
Depreciation and amortization	$	26,217		$	14,753		$	28,091	$	2,067			$	71,128
Goodwill impairment	$	73,442		$	109,100		$	—	$	—			$	182,542
Income from operations	$	(54,103	)	$	(95,115	)	$	19,136	$	(48,806	)		$	(178,888	)
Interest expense													$	(61,243	)
Other													$	(20,903	)
Loss from continuing operations before benefit for income taxes and share of net income from joint venture													$	(261,034	)
Share of net income from joint venture	$	(14,390	)	—			—		—				$	(14,390	)
Expenditures for long-lived assets	$	36,660		$	6,459		$	14,645	$	6,272			$	64,036
Total assets	$	356,387		$	297,947		$	802,770	$	44,466		(b)	$	1,501,570
Year Ended December 31, 2017
Net sales	$	336,852		$	186,602		$	98,329	$	(1,990	)	(a)	$	619,793
Depreciation and amortization	$	24,491		$	14,657		$	12,088	$	1,170			$	52,406
Income from operations	$	34,405		$	23,440		$	13,271	$	(38,002	)		$	33,114
Interest expense													$	(52,085	)
Other													$	(39,902	)
Loss from continuing operations before benefit for income taxes and share of net income from joint venture													$	(58,873	)
Share of net income from joint venture	$	5,211		—			—		—				$	5,211
Expenditures for long-lived assets	$	24,056		$	5,443		$	—	$	6,907			$	36,406
Total assets	$	428,321		$	385,558		$	353,208	$	307,916		(b)	$	1,475,003
Year Ended December 31, 2016
Net sales	$	326,138		$	180,330		$	80,057	$	(1,571	)	(a)	$	584,954
Depreciation and amortization	$	22,189		$	15,604		$	12,501	$	427			$	50,721
Income from operations	$	29,490		$	24,060		$	9,840	$	(28,611	)		$	34,779
Interest expense													$	(62,870	)
Other													$	(2,775	)
Loss from continuing operations before benefit for income taxes and share of net income from joint venture													$	(30,866	)
Share of net income from joint venture	$	5,938		—			—		—				$	5,938
Expenditures for long-lived assets	$	23,077		$	3,125		$	2,227	$	3,465			$	31,894

_______________________________

(a) Includes eliminations of intersegment transactions which occur during the ordinary course of business.

(b) Total assets in Mobile Solutions includes $20.4 million and $39.8 million as of December 31, 2018 and 2017, respectively, related to the investment in our 49% owned joint venture (Note 10).

The following table summarizes the net sales and income (loss) from operations from the Paragon Medical and NN Vandalia acquisitions in the Life Sciences group and other acquisitions in the Life Sciences and Power Solutions groups for the years ended December 31, 2018 and 2017.



	Year Ended December 31,
	2018		2017
Net sales
Paragon Medical	$	116,998	$	—
NN Vandalia	30,668		6,682
Other	11,968		—

Income (loss) from operations
Paragon Medical	$	8,086	$	—
NN Vandalia	1,532		(458		)
Other	284		—

The following table summarizes long-lived tangible assets by geographical region.



	Property, Plant, and Equipment, Net As of December 31,
	2018		2017
United States	$	235,975	$	173,269
Europe	50,143		25,288
Asia	42,657		26,078
Mexico	7,647		7,544
S. America	24,606		27,101
All foreign countries	$	125,053	$	86,011
Total	$	361,028	$	259,280